Rabeprazole Injection IP
Rabilict
RABILICT Injection contains Rabeprazole Sodium 20mg, a fast-acting proton pump inhibitor (PPI) formulated for intravenous use in patients who require rapid and effective acid suppression. It is used for the management of stomach ulcers, gastroesophageal reflux disease (GERD), Zollinger–Ellison syndrome, and severe acidity-related disorders when oral therapy is not suitable. Rabeprazole works by inhibiting gastric acid secretion at the proton pump level, promoting quick healing of erosive conditions and reducing symptoms such as severe heartburn, pain, and discomfort. Its IV administration ensures immediate therapeutic action, making RABILICT Injection ideal for hospitalized patients, post-operative care, and emergency GI management where oral intake is restricted.
